Loading...
Loading...
Impax Laboratories, Inc.
IPXL is up around 1% in early Wednesday trading after the company received final FDA approval today for generic Doryx 75 and 100mg tablets.
At last check, shares of Impax were up 23 cents to $20.73, a gain of 1.1%.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in